Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

EPAD

EU flag

EU consortium focuses on antibiotic ‘husbandry’

IMI-backed group to research ways to tackle antimicrobial resistance

- PMLiVE

EFPIA promotes pharma’s contribution to Europe

Launches Pharmafigures website to detail industry investment

- PMLiVE

The price is right: drug reimbursement in Europe

EFPIA's director general argues that drug pricing is not a gameshow

Novartis building

Novartis launches Alzheimer’s prevention study

Will test two treatments in people with genetic risk of dementia

- PMLiVE

Another Alzheimer’s failure as Targacept trial disappoints

Targacept drops development of drug after disappointing study results

EU flag

EC sets out its pharma priorities

New strategy puts the industry at the heart of Europe’s economic growth prospects, saysEFPIA

- PMLiVE

UK’s MRC launches public-private push on dementia research

AstraZeneca, GSK and J&J will support £16m programme

EU flag

EFPIA: pharma must play key role in healthcare reform

Trade body publishes strategy to put industry at heart of economic growth

- PMLiVE

AFFiRiS claims a first in Alzheimer’s disease therapy

Says AD04 is first drug to demonstrate disease modification

Bristol-Myers Squibb (BMS) building

BMS buys Alzheimer’s player iPierian in $725m deal

Takes control of several promising candidates for neurodegenerative diseases

- PMLiVE

The changing regulatory environment

Code of practice changes are encouraging transparency in pharma/HCP relationships

- PMLiVE

EFPIA hires director of European affairs

Elizabeth Kuiper will join trade body on May 1

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links